tiprankstipranks
TipRanksTop Financial ExpertsInsidersChristopher Maxwell Fullerton

Christopher Maxwell Fullerton Insider Profile

4 Followers
Christopher Maxwell Fullerton, Director at Paradigm Biopharmaceuticals Ltd., holds 1.07M shares in Paradigm Biopharmaceuticals Ltd. (Ticker: PBIGF), holds 254.06K shares in XTEK Limited (Ticker: DE:X9L), holds 0.00 shares in Life (Ticker: CORFF). Most recently, Christopher Maxwell Fullerton Bought ― shares of Paradigm Biopharmaceuticals Ltd. on Nov 19, 2019 for an estimated value of 301.05K.
tipranks
Christopher Maxwell Fullerton

Christopher Maxwell Fullerton
Paradigm Biopharmaceuticals Ltd. (PBIGF)
Director

Ranked #6,694 out of 98,909 Corporate Insiders

Profitable Transactions

100%
3 out of 3 Profitable Transactions

Average Return

+128.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$192K
100.00%
A breakdown of Christopher Maxwell Fullerton's holdings

Insider Roles

Paradigm Biopharmaceuticals Ltd.
(PBIGF)
Director
Roles that Christopher Maxwell Fullerton holds in companies

Most Profitable Insider Trade

Stock:
Paradigm Biopharmaceuticals Ltd.
(PBIGF)
Rating:Informative Buy
Date:Jul 03, 2019 - Jul 03, 2020
Return:+136.60%
The most profitable trade made by Christopher Maxwell Fullerton

Christopher Maxwell Fullerton's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Paradigm Biopharmaceuticals Ltd.
Nov 19, 2019
Director
Informative Buy
301.05K
$191.53K
X9L
XTEK Limited
CORFF
Life
$0.00
E7G
Environmental Group Limited
List of latest transactions for each holding click on a transaction to see Christopher Maxwell Fullerton's performance on stock

Christopher Maxwell Fullerton insider profile FAQ

What is the percentage of profitable transactions made by Christopher Maxwell Fullerton?
The percentage of profitable transactions made by Christopher Maxwell Fullerton is 100%.
    What is the average return per transaction made by Christopher Maxwell Fullerton?
    The average return per transaction made by Christopher Maxwell Fullerton is 128.40%.
      What stocks does Christopher Maxwell Fullerton hold?
      Christopher Maxwell Fullerton holds: PBIGF, DE:X9L, CORFF, DE:E7G stocks.
        What was Christopher Maxwell Fullerton’s latest transaction?
        Christopher Maxwell Fullerton latest transaction was an Informative Buy of $301.05K.
          What was Christopher Maxwell Fullerton's most profitable transaction?
          Christopher Maxwell Fullerton’s most profitable transaction was an Informative Buy of PBIGF stock on July 3, 2019. The return on the trade was 136.60%.
            What is Christopher Maxwell Fullerton's role in Paradigm Biopharmaceuticals Ltd.?
            Christopher Maxwell Fullerton's role in Paradigm Biopharmaceuticals Ltd. is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.